These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8847095)

  • 1. Immunoglobulin kappa chain 3' enhancer fragment allows specific expression of gene constructs in B-cells.
    Schenkel J
    Immunol Lett; 1995 Nov; 48(1):73-5. PubMed ID: 8847095
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-type specific regulation of a kappa immunoglobulin gene by promoter and enhancer elements.
    Queen C; Foster J; Stauber C; Stafford J
    Immunol Rev; 1986 Feb; 89():49-68. PubMed ID: 3081432
    [No Abstract]   [Full Text] [Related]  

  • 3. Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.
    Fulton R; Van Ness B
    Nucleic Acids Res; 1993 Oct; 21(21):4941-7. PubMed ID: 8177743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell-specific demethylation: a novel role for the intronic kappa chain enhancer sequence.
    Lichtenstein M; Keini G; Cedar H; Bergman Y
    Cell; 1994 Mar; 76(5):913-23. PubMed ID: 8124725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region.
    Betz AG; Milstein C; González-Fernández A; Pannell R; Larson T; Neuberger MS
    Cell; 1994 Apr; 77(2):239-48. PubMed ID: 8168132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.
    Shaffer AL; Peng A; Schlissel MS
    Immunity; 1997 Feb; 6(2):131-43. PubMed ID: 9047235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An AP1 binding site upstream of the kappa immunoglobulin intron enhancer binds inducible factors and contributes to expression.
    Schanke JT; Marcuzzi A; Podzorski RP; Van Ness B
    Nucleic Acids Res; 1994 Dec; 22(24):5425-32. PubMed ID: 7816634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers.
    Fulton R; van Ness B
    Nucleic Acids Res; 1994 Oct; 22(20):4216-23. PubMed ID: 7937148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin kappa light chain gene promoter and enhancer are not responsible for B-cell restricted gene rearrangement.
    Goodhardt M; Babinet C; Lutfalla G; Kallenbach S; Cavelier P; Rougeon F
    Nucleic Acids Res; 1989 Sep; 17(18):7403-15. PubMed ID: 2508061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
    Kawakami K; Scheidereit C; Roeder RG
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4700-4. PubMed ID: 3133660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
    Lin MM; Green NS; Zhang W; Scharff MD
    Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription.
    Atchison ML; Perry RP
    Cell; 1987 Jan; 48(1):121-8. PubMed ID: 3098435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant downregulation of IgH 3' enhancer activity and c-myc expression in a plasmacytoma x fibroblast environment: implications for dysregulation of translocated c-myc.
    Thøger Andersen AS; Jensen AW; Grant P; Arulampalam V; Pettersson S; Junker S
    Mol Immunol; 1997 Feb; 34(2):97-107. PubMed ID: 9188842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences.
    Sen R; Baltimore D
    Mol Cell Biol; 1987 May; 7(5):1989-94. PubMed ID: 3110599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunoglobulin promoter displays cell-type specificity independently of the enhancer.
    Foster J; Stafford J; Queen C
    Nature; 1985 May 30-Jun 5; 315(6018):423-5. PubMed ID: 3923370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the immunoglobulin kappa 3' enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active core.
    Meyer KB; Ireland J
    Nucleic Acids Res; 1994 May; 22(9):1576-82. PubMed ID: 8202357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Every enhancer works with every promoter for all the combinations tested: could new regulatory pathways evolve by enhancer shuffling?
    Kermekchiev M; Pettersson M; Matthias P; Schaffner W
    Gene Expr; 1991 Apr; 1(1):71-81. PubMed ID: 1668145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression.
    Hoyos B; Ballard DW; Böhnlein E; Siekevitz M; Greene WC
    Science; 1989 Apr; 244(4903):457-60. PubMed ID: 2497518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.
    Meyer KB; Sharpe MJ; Surani MA; Neuberger MS
    Nucleic Acids Res; 1990 Oct; 18(19):5609-15. PubMed ID: 2120679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.